Results for
"[search-keyword]"
Sponsor content
310 result(s) found, displaying 11 to 20
-
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for TRUQAP capivasertib 200 mg film coated tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for TRUQAP capivasertib 160 mg film coated tablet blister pack.
-
Jul-2024Prescription medicine evaluationActive ingredient: osimertinib mesilate.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for LOKELMA sodium zirconium cyclosilicate hydrate 5 g powder for oral suspension sachet.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for LOKELMA sodium zirconium cyclosilicate hydrate 10 g powder for oral suspension sachet.
-
Prescription medicine decision summaryTruqap (capivasertib), in combination with fulvestrant, is approved for the treatment of adult patients with locally advanced or metastatic breast cancer.
-
-
Prescription medicine decision summaryLokelma (sodium zirconium cyclosilicate hydrate) was approved for the treatment of hyperkalaemia in adult patients. Lokelma binds to potassium in the gut and is used to treat high levels of potassium in the blood.
-
Prescription medicine registrationActive ingredients: dapagliflozin propanediol monohydrate, sitagliptin phosphate monohydrate.